Janet Woodcock of the FDA testifies before Congress in 2016. She spoke to reporters this week about COVID-19 treatments.  (Tom Williams/CQ Roll Call)

Drug touted by Trump may not alleviate pandemic’s toll on the poor

People most impacted by COVID-19 may face barriers in getting costly treatments

Posted November 24, 2020 at 2:17pm